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Introduction 
Single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) is a 
well-established technique for the diagnosis and risk stratification of patients with suspected or 
known coronary artery disease (CAD) (1). Conventional Anger camera systems for SPECT imaging 
use sodium iodide crystals and parallel-hole collimators. However, although the latest developments 
have enhanced image quality performance of these systems, some technical limits are still present, 
as poor energy resolution prolonged imaging time, low spatial resolution and the need for relatively 
large doses of radiopharmaceuticals (2). The novel gamma cameras with semiconductor Cadmium-
Zinc-Telluride (CZT) detectors have been introduced recently (2). In this new system, CZT 
semiconductors, that directly convert radiation into electric signals, have replaced the conventional 
sodium iodide crystals allowing an improvement in terms of image accuracy and acquisition time 
(3-5). Different studies demonstrated the good diagnostic performance of these new cameras in the 
routine clinical practice (2). In particular, previous studies demonstrated that CZT-SPECT provides 
adequate risk stratification results of patients referred to MPI for their suspected or known CAD (6). 
Despite a direct comparison between conventional Anger and CZT cameras has been performed (7) 
in the evaluation of patients referred for MPI, a better correlation of the all semi-quantitative 
perfusion and functional parameters needs to be provided.  Moreover, no studies have been 
performed using an external validation standard such as coronary angiography for comparing the 
diagnostic accuracy of the two imaging modalities in the evaluation of patients with suspected or 
known CAD. Thus, we conducted a retrospective study to compare the ability of CZT camera (D-
SPECT) with that of conventional SPECT in detecting myocardial perfusion and functional 
abnormalities in patients referred for clinical evaluation of suspected or known CAD at our 
institution using semi-quantitative analysis of myocardial perfusion and function. 
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Methods 
Study Population 
Between February 2016 and May 2017, 517 consecutive patients with suspected or known CAD 
underwent gated stress MPI for the assessment of myocardial ischemia at our institution. Of the 
517 patients considered for the purpose of the present investigation, 86 (16%) patients had 
coronary angiography data available. 
 
Pre-scan likelihood of CAD 
As part of the baseline examination, clinical teams collected information on traditional 
cardiovascular risk factors, including age, gender, blood pressure, smoking history, serum 
cholesterol, family history of CAD, rest ECG characteristics, diabetes and its complications 
(including neuropathy, nephropathy, peripheral vascular disease, and retinopathy), as well as the 
results of ECG stress testing. Hypertension was defined as a known history of systolic blood 
pressure >140 mmHg or the use of antihypertensive medication. Hypercholesterolemia was defined 
as a known history of dyslipidemia or treatment with cholesterol-lowering medication. Patients 
were classified as having diabetes if they had a previous diagnosis of diabetes or were receiving 
treatment with oral hypoglycemic drugs or insulin. A positive family history of CAD was defined 
as the presence of CAD in first-degree relatives. These data were verified and complemented with 
demographic and clinical information collected from medical records. From these clinical variables, 
the pre-test CAD likelihood was calculated for each patient by dedicated software based on 
Bayesian analysis of pre-scan patients’ data (Cadenza, version 5.04.3, Advanced Heuristics, Inc., 
Bainbridge Island, Washington) (8). For patients who underwent pharmacologic stress testing, the 
pre-test likelihood was calculated without using the stress test parameters. . According to pre-test 
likelihood of CAD, patients with a likelihood score <0.15 were considered at low risk, while those 
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with a score between 0.15 and 0.85 were considered at intermediate risk. In patients with known 
CAD, the software automatically calculated the pre-test likelihood of ischemia. 
 
Stress protocol 
All patients underwent stress technetium-99m (Tc-99m) sestamibi gated MPI by physical exercise 
or dipyridamole stress test, according to the recommendations of the European Association of 
Nuclear Medicine and European Society of Cardiology (9). In all patients, beta-blocking 
medications and calcium antagonists were withheld for 48 hours and long-acting nitrates for 
12 hours before testing. For patient undergoing exercise test, symptom-limited treadmill 
standardized protocols were performed, with monitoring of heart rate and rhythm, blood pressure, 
and electrocardiography (ECG). Test endpoints were achievement of 85% maximal predicted 
heart rate, horizontal or downsloping ST-segment depression >2 mm, ST-segment elevation 
>1 mm, moderate to severe angina, systolic blood pressure decrease >20 mm Hg, blood pressure 
>230/120 mm Hg, dizziness, or clinically important cardiac arrhythmia. For dipyridamole stress 
test, patients were instructed not to consume products containing caffeine for 24 hours before the 
test. Dipyridamole was infused at dose of 0.142 mg·kg−1·minute−1intravenous over 4 minutes. A 
dose of 100 mg of aminophylline was administered intravenously in the event of chest pain or 
other symptoms, or after significant ST depression. At peak exercise, or 4 minutes after 
completion of dipyridamole infusion, a bolus of 370 MBq of Tc-99m sestamibi was intravenously 
injected. Patients continued the exercise for additional 60 seconds after tracer injection. For both 
types of stress, heart rate, blood pressure, and 12-lead ECG data were recorded at rest, at the end 
of each stress stage, at peak stress and in the delay phases at rest. Maximal degree of ST-segment 
change at 80 ms after the J-point of the ECG was measured and assessed as horizontal, 
downsloping or upsloping. In our institution stress protocol-only is used, thus patients with 
negative findings were not reinjected at rest. 
5 
 
Conventional SPECT acquisition protocol 
Anger camera: E.CAM 
For both types of stress, imaging was started 30 minutes after tracer injection using a dual-head 
rotating gamma camera (E.CAM, Siemens Medical Systems, Hoffman Estates, IL, USA) 
equipped with a low-energy, high-resolution collimator and connected with a dedicated computer 
system (10). No attenuation or scatter correction was used. For gating, a cardiac cycle was 
divided into eight frames. The R-R interval and heart rate histogram were recorded to monitor 
arrhythmia. An average R-R interval of ±15% was accepted for gating. Perfusion imaging was 
reconstructed by summing the gated data at each projection into an “ungated” raw data file before 
low phase prefiltering and ramp filtered back projection. An automated software program (e-soft, 
2.5, QGS/QPS, Cedars-Sinai Medical Center, Los Angeles, CA) was used to calculate left 
ventricular (LV) volumes and ejection fraction (EF) and the scores incorporating both the extent 
and severity of perfusion defects, using standardized segmentation of 17 myocardial regions (11). 
Briefly, this commercial package determines reconstruction limits for the projection dataset, 
reconstructs the projection images into transaxial images using standard filtered backprojection, 
and then reorients the transaxial images into short-axis images. LV contours were checked 
visually and manually adjusted if the computer-generated automatic contours were found to be 
incorrect. Quantitative defect extent and severity were defined from sex-specific normal limits, 
and summed stress score (SSS) was obtained by adding the scores of the 17 segments (0 = normal 
to 4 = absent perfusion) of the stress images. A similar procedure is applied to the resting images 
to calculate the summed rest score (SRS). The summed difference score (SDS) represents the 
difference between the stress and rest scores and is taken to be an index of ischemic burden. A 
post-stress LVEF >45% and a summed stress score <3 were considered normal (12). The total 
perfusion defect (TPD) of the stress and resting images was generated, representing the defect 
extent and severity and expressed as a percentage of the left ventricular myocardium (13).  
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Patients were categorized into 3 groups of stress TPD (normal <5%; mild-moderate from 5% to 
15% and severe abnormality >15%) (14). 
 
CZT Camera: D-SPECT 
The CZT camera recordings were obtained immediately after each rest or stress Anger camera 
scans. The D-SPECT technology (DSPECT, Spectrum Dynamics, Caesarea, Israel) (15) uses 9 
pixilated cadmium zinc telluride crystal detector columns mounted vertically spanning a 90° 
geometry. Each of the columns consists of 1,024 (16 x 64) 5-mm thick cadmium zinc telluride 
crystal elements (2.46 x 2.46 mm). Square-hole tungsten collimators are fitted to each of the 
detectors, which are shorter than conventional low-energy, high-resolution collimators, yielding 
significantly better geometric speed. Data are acquired focusing on the heart by the detectors 
rotating in synchrony and saved in list mode. The CZT camera uses a proprietary Broadview 
reconstruction algorithm based on the maximum likelihood expectation maximization algorithm 
(16–18). Images were acquired with the patient in a semi recumbent position. A 10-s pre-scan 
acquisition was performed to identify the location of the heart and to set the angle limits of scanning 
for each detector (region of interest– centric scanning). A 4-min rest acquisition (120 projections 
per detector, 2 s per projection) was performed after resting conventional SPECT imaging, and a 2-
min acquisition (1 s per projection) followed the post-stress conventional SPECT imaging. Summed 
and gated projections were reconstructed with an iterative maximum likelihood expectation 
maximization algorithm using 7 and 4 iterations, respectively. An automated software program 
(QGS/QPS, Cedars-Sinai Medical Center, Los Angeles, CA) was used to calculate LV volumes, 
EF and the scores incorporating both the extent and severity of resting and post-stress perfusion 
defects, using standardized segmentation of 17 myocardial regions (SSS, SRS, SDS and TPD) 
(11). 
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Statistical analysis 
Statistical analysis was performed with a commercially available software package (SPSS, version 
20.0 for Windows, SPSS Inc., Chicago, IL, USA) and Statistics with R (version 3.4.0). Semi-
quantitative variables were expressed as mean ± SD, and categorical variables as frequencies or 
percentage. Correlations between SSS, SRS, EDV, ESV, LVEF and TPD, by D-SPECT versus 
conventional SPECT were evaluated by linear regression, and differences between the two methods 
were assessed by Bland-Altman analysis (19). Concordance between the methods was assessed 
using kappa analysis. A p-value of less than 0.05 was considered as statistically significant. 
Comparison of continuous data between groups was performed using the two-sided Student’s t test. 
In patients with angiographic available data, sensitivity, specificity, positive predictive value (PPV), 
negative predictive value (NPV) and diagnostic accuracy for the detection of CAD (≥50% luminal 
narrowing) were calculated for conventional SPECT and D-SPECT. 
 
Results 
Patient characteristics 
Table 1 summarizes the clinical characteristics of the patient population. The study group 
comprised 287 (55%) with suspected and 230 (45%) with known CAD. In patients with suspected 
CAD, pre-scan likelihood of disease was low in 185 (64%) patients and intermediate to high in 102 
(36%) patients. Of the overall 517 patients analyzed, 266 (51%) performed treadmill exercise stress 
test whereas 251 (49%) dipyridamole stress test.  
 
Correlation of perfusion scores 
The mean perfusion scores of conventional and D-SPECT are summarized in Table 2. 
As shown in Figure 1A, an excellent linear correlation between SSS by conventional SPECT versus 
SSS by D-SPECT (r=0.808, p <0.001) has been demonstrated. In the Bland-Altman analysis,  
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(Figure 1B) the mean difference in SSS between conventional SPECT and D-SPECT was 1.3%. 
The lower and upper limits of agreement between the two techniques were −7.46% to 10%. 
Similarly, SRS by D-SPECT excellently correlated to SRS by conventional SPECT (r= 0.915,  
p<0.001) (Figure 2A). The Bland-Altman analysis for the SRS between conventional SPECT and 
D-SPECT showed a mean difference of 0.55 % and (Figure 2B) and the lower and upper limits of 
agreement between the two techniques −4.85% to 6% (Figure 2B).  
As well, semi-quantitative stress TPD by D-SPECT demonstrated linear correlation with 
conventional SPECT (r=0.892, p< 0.001) (Figure 3A).  The Bland-Altman analysis for the TPD 
between conventional SPECT and D-SPECT showed a mean difference of 0.54 % and (Figure 3B) 
and the lower and upper limits of agreement between the two techniques −8.86% to 9.94% (Figure 
3B).  
 
Correlation of functional scores  
The mean functional scores of conventional and D-SPECT are summarized in Table 2. 
As shown in Figure 4A, an excellent linear correlation between EDV by conventional SPECT 
versus EDV by D-SPECT (r=0.911, p <0.001) has been demonstrated. In the Bland-Altman 
analysis, the mean difference in EDV between conventional SPECT and D-SPECT was -13% 
(Figure 4B). The lower and upper limits of agreement between the two techniques were −39.9% to 
13.7% (Figure 4B). 
Similarly, ESV by D-SPECT excellently correlated to ESV by conventional SPECT (r= 0.926,  
p<0.001) (Figure 5A). The Bland-Altman analysis for the ESV between conventional SPECT and 
D-SPECT showed a mean difference of -8% and (Figure 5B) and the lower and upper limits of 
agreement between the two techniques −17.7% to 17.7% (Figure 5B).  
The correlation between LVEF by the methods was linear over a wide range of EF values (r =0.82, 
p<0.001) (Figure 6A).  
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The Bland-Altman analysis for the EF between conventional SPECT and D-SPECT showed a mean 
difference of 3.4% and (Figure 6B) and the lower and upper limits of agreement between the two 
techniques −15.6% to 22.4% (Figure 6B). 
 
Concordance of Stress Perfusion Findings 
Patients were analyzed into 3 groups of stress TPD (normal <5%; mild-moderate from 5% to 15%; 
and severe abnormality> 15%). By conventional SPECT, 198 patients had normal MPI and 319 had 
abnormal MPI, 252 mild or moderate and 67 severe defects. By D-SPECT, 254 patients had normal 
MPI and 263 abnormal MPI, 188 mild or moderate and 75 severe perfusion deficits. The 
concordance between the methods has showed in Table 3.  
In patients with normal findings by conventional SPECT, the mean SSS, SRS and TPD were 
2.61±2, 0.22±0.6 and 2.31±1, respectively. The mean EDV, ESV and EF were 78.88±23, 32.09±17 
and 61.72±12 respectively. In patients with mild or moderate defects, the mean SSS, SRS and TPD 
were 7.29±3, 2.23±3 and 8.36±3, respectively. The mean EDV, ESV and EF were 70.19±28, 
28.86±22 and 64.3±17 respectively. In patients with severe defects, the mean SSS, SRS and TPD 
were 21.36±8, 17.33±9 and 30.22±11, respectively. The mean EDV, ESV and EF were 121.85±55, 
75.37±46 and 41.37±14 respectively. 
In patients with normal findings by D-SPECT, the mean SSS, SRS and TPD were 1.39±1, 0.7±0.4 
and 2.08±1.2, respectively. The mean EDV, ESV and EF were 79.51±27, 32.46±19 and 61.61±10 
respectively. In patients with mild or moderate defects, the mean SSS, SRS and TPD were 6.47±3, 
1.86±2 and 8.41±3, respectively. The mean EDV, ESV and EF were 92.98±29, 42.02±20 and 
56.85±10 respectively. In patients with severe defects, the mean SSS, SRS and TPD were 20.07±8, 
14.84±8 and 29.33±12, respectively. The mean EDV, ESV and EF were 147.28±60, 94.34±54 and 
39.34±12 respectively. 
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Diagnostic performance of conventional SPECT compared to D-SPECT 
Diagnostic performance of conventional and CZT SPECT is showed in Figure 7. In 86 patients with 
coronary angiography data available, conventional SPECT yields sensitivity and specificity of 95% 
and 75% respectively, while for D-SPECT sensitivity and specificity of 86% and 85% were 
recorded. No statistical differences in sensitivity and specificity have been observed between the 
two methods (p=0.12 and p=0.36, respectively). Moreover, the diagnostic accuracy for conventional 
SPECT and D-SPECT was not different (88% and 84%, respectively, p=0.5). As well, the PPV and 
NPV for conventional and D-SPECT were 88% and 84%, p=0.48 and 87% and 85%, p=0.8, 
respectively.  
 
Discussion 
Coronary artery disease (CAD) remains one of the leading cause of mortality in the developed 
countries, however epidemiologic data show that improved control of cardiac risk factors has 
resulted in a temporal decrement in the incidence and severity of CAD as well as its related 
mortality. (20) Stress single-photon emission computed tomography myocardial perfusion imaging 
(MPI) is a well-established modality for the evaluation and analysis of global and regional left 
ventricular function in patients with suspected or known CAD. This technique has clinical 
advantages including high sensitivity and high negative predictive value (NPV) (21). 
Stress myocardial SPECT imaging has been markedly enhanced by the recent commercialization of 
cameras with semiconductor with cadmium-zinc-telluride (CZT) detectors (22). These new cameras 
offer higher energy resolution and higher count sensitivity, thereby allowing improved image 
quality overcoming the considerable limitations of the conventional gamma camera as the 
prolonged time to scan acquisition and the radiation dose (23). CZT cameras use a different imaging 
technique compared to conventional SPECT cameras, with a stationary multi-pinhole design 
focused on the heart. This new geometric design and the new detector material combined with novel 
reconstruction algorithms led to improved diagnostic performance. Since the introduction of the 
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novel dedicated cardiac CZT camera in 2006, several clinical studies confirmed the high 
performance of this new camera (24). These studies evaluated its physical characteristics and the 
overall performances in comparison to conventional Anger cameras, and tested the potential to 
reduce scan times and/or tracer activity and their effectiveness in clinical use (4, 14, 21, 22). The 
superior performances reported for CZT system in comparison to conventional Anger cameras, are 
strictly dependent on the intrinsically different technology and acquisition techniques, which are, in 
clinical conditions, potentially capable of producing significantly different results (25). 
Quantitative analysis has been shown to be useful in comparing sequential MPI studies (26, 27) and 
assessing the effectiveness of invasive as well as medical treatments in patients with CAD (28) and 
to provide evidence of the generalizability of the SPECT MPI results with the new system. 
Sharir et al. (14) have compared the conventional gamma camera systems and new high-speed 
technology, demonstrating that high-speed stress and rest TPD correlated linearly with conventional 
SPECT TPD (r = 0.95 and 0.97, respectively, p < 0.0001), with good concordance in the 3 vascular 
territories (k for the left anterior descending coronary artery, left circumflex coronary artery, and 
right coronary artery were 0.73, 0.73, and 0.70, respectively; >90% agreement). 
Moreover, a recent multicenter study evaluating a new solid-state cardiac camera showed diagnostic 
performance comparable to that of standard SPECT cameras, with superior image quality and 
significantly shorter acquisition time (7). In the present investigation, D-SPECT performance was 
compared with conventional SPECT in detecting perfusion abnormalities by stress-only Tc-99m 
sestamibi protocol, in 517 patients referred for evaluation of CAD at our institution. The results of 
our study highlight excellent correlation between D-SPECT and traditional camera in the evaluation 
of perfusion scores (SSS, SRS, TPD) and parameters of left ventricular function (EDV, ESV, 
LVEF). However, comparing mean values of SSS, SRS, TPD, EDV, ESV and EF some differences 
were found between conventional SPECT and D-SPECT.  
The diagnostic accuracy evaluated in the 86 patients with coronary angiography available data, was 
not significantly different between conventional camera and D-SPECT but showed a trend to a 
12 
 
higher specificity (75% compared to 85% by traditional camera). These findings may be explained 
by the functioning of novel CZT cameras: patient position (upright or supine) and the position of 
the detectors closer to patients body reduce attenuation artifacts, limiting the overestimation of the 
perfusion defect scores obtained by conventional SPECT; similarly higher patient comfort and 
short-time acquisition of D-SPECT decrease motion artifacts. Moreover, our results showed that D-
SPECT has more normal scans, as already demonstrated by Lima et al. (6), with a modest 
agreement and concordance between both cameras, when patients were categorized on the basis of 
TPD (agreement 61%, k=0.37). 
 
Conclusion 
The novel CZT camera provides excellent image quality, which is equivalent to standard 
myocardial SPECT, despite a short scan time of less than half the standard time. 
Quantitative measures of myocardial perfusion and function, obtained using normal limits specific 
for the new technology, correlated extremely well with respective conventional SPECT measures.  
These findings support the use of this technology in nuclear laboratories using various 
radiopharmaceutical and stress protocols, evaluating patient populations with suspected or known 
CAD. 
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Table 1. Clinical characteristics of patients  
 n = 517 
Age (years) 63 ± 10 
Male gender  377 (73) 
Diabetes  177 (34) 
Dyslipidemia  377 (73) 
Smoking  232 (45) 
Hypertension  447 (86) 
Angina-like symptom  186 (36) 
Family history of CAD  255 (49) 
Previous MI  174 (34) 
Previous revascularization procedures  197 (38) 
BMI ≥ 30  126 (24) 
Data are presented as mean ±SD or n (%).  
CAD, coronary artery disease; MI, myocardial infarction; BMI, body mass index. 
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Table 2. Conventional and D-SPECT perfusion and functional scores 
   N  Conventional  
SPECT 
D-SPECT p-value 
SSS 517 7.32±7 5.95±7 .000 
SRS  250 3.41±7 2.86±6 .000 
SDS 250 2.97±3 4.16±3 .000 
TPD 517 8.88±10 8.34±10 .010 
EDV 472 80.16±35 93.3±40 .000 
ESV 472 36±28 44.1±33 .000 
EF 472 60.39±16 56.9±12 .000 
Data are presented as mean ±SD. 
SSS, summed stress score; SRS, summed rest score;  
SDS, summed difference score; TPD, total perfusion deficit; 
EDV, end-diastolic volume; ESV, end-systolic volume; EF, ejection fraction. 
19 
 
Table 3. Concordance of perfusion score findings 
    D-SPECT  
 
 
Conventional SPECT 
  
 
Normal  
Mild-moderate 
perfusion  
defect 
Severe 
perfusion 
defect 
Total 
Normal 138 59 1 198 
Mild-moderate perfusion defect  116 121 15 252 
Severe perfusion defect 0 8 59 67 
Total 254 188 75 517 
 Agreement 61%, kappa = 0.37  
SPECT, single-photon emission computed tomography 
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Figure 1. (A) Correlation of Quantitative SSS by D-SPECT versus conventional SPECT. (B) 
Bland-Altman plot for SSS by D-SPECT versus conventional SPECT. 
A 
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Figure 2. (A) Correlation of Quantitative SRS by D-SPECT versus conventional SPECT. (B) 
Bland-Altman plot for SRS by D-SPECT versus conventional SPEC 
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Figure 3. (A) Correlation of TPD (%) by D-SPECT versus conventional SPECT. (B) Bland-Altman 
plot for TPD (%) by D-SPECT versus conventional SPECT 
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Figure 4. (A) Correlation of EDV by D-SPECT versus conventional SPECT. (B) Bland-Altman 
plot for EDV by D-SPECT versus conventional SPECT 
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Figure 5. (A) Correlation of ESV by D-SPECT versus conventional SPECT. (B) Bland-Altman plot 
for ESV by D-SPECT versus conventional SPECT. 
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Figure 6. (A) Correlation of EF by D-SPECT versus conventional SPECT. (B) Bland-Altman plot 
for EF by D-SPECT versus conventional SPECT. 
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Figure 7. Diagnostic performance of conventional SPECT compared to D-SPECT 
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